WINDTREE THERAPEUTICS INC Business Operations Contracts & Agreements
21 Contracts & Agreements
- Agency Agreements (1 contract)
- Collaboration Agreements (6)
- Development Agreements (3)
- Indemnification Agreements (4)
- Sales Agreements (2)
- Services Agreements (2)
- Supply Agreements (2)
- Voting Agreements (1)
- Agreement for Scientific Collaboration between Universita degli Studi di Milano-Bicocca and CVie Therapeutics Ltd, a wholly-owned subsidiary of the Registrant, dated March 19, 2021 (Filed With SEC on May 13, 2021)
- Amended and Restated Sublicense and Collaboration Agreement, dated December 3, 2004, by and between Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) and... (Filed With SEC on November 16, 2020)
- Amended and Restated Supply Agreement, dated as of December 3, 2004, by and between Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) and Laboratorios Del Dr.... (Filed With SEC on November 16, 2020)
- Collaboration Agreement dated as of October 10, 2014, by and between Battelle Memorial Institute and Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) (Filed With SEC on November 16, 2020)
- Form of Indemnification Agreement between Windtree and certain named directors (Filed With SEC on April 16, 2019)
- Indemnification Letter Agreement, dated December 21, 2018 by and between the Company and Lees Pharmaceutical Holdings Limited (Filed With SEC on December 21, 2018)
- Second Amendment to Collaboration Agreement between the Company and Battelle dated March 31, 2016 (Filed With SEC on April 5, 2016)
- Amendment No. 1 dated February 11, 2016 to the At-the-Market Equity Sales Agreement dated February 11, 2013 by and between the Company and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on February 16, 2016)
- Form of Indemnification Agreement between the Company and its named executive officers, including Craig Fraser, and directors (Filed With SEC on February 3, 2016)
- Amendment dated as of August 4, 2015 to Collaboration Agreement dated as of October 14, 2014 between Discovery and Battelle Memorial Institute (Filed With SEC on August 10, 2015)
- Amendment effective May 7, 2015, to Research and Development Services Agreement dated as of June 22, 2012, by and between Discovery and Battelle Memorial Institute (Filed With SEC on May 11, 2015)
- Collaboration Agreement dated as of October 10, 2014, by and between Battelle and Discovery (Filed With SEC on November 7, 2014)
- Master Services Agreement dated October 24, 2013 between Discovery and DSM (Filed With SEC on November 12, 2013)
- Pharmaceutical Manufacturing and Supply Agreement dated August 7, 2013 between Discovery and DSM Pharmaceuticals, Inc (Filed With SEC on August 8, 2013)
- At-the-Market Equity Offering Sales Agreement between Stifel, Nicolaus & Company, Incorporated and the Company, dated February 11, 2013 (Filed With SEC on February 13, 2013)
- Indemnification Agreement dated as of January 3, 2013, between the Company and Joseph M. Mahady (Filed With SEC on January 4, 2013)
- RESEARCH AND DEVELOPMENT SERVICES AGREEMENT (Filed With SEC on August 14, 2012)
- Product Development and Supply Agreement between Discovery and Lacey Manufacturing Company, a Division of Precision Engineered Products, LLC (Filed With SEC on May 15, 2012)
- Sales Agency Agreement between Lazard Capital Markets LLC and the Company, dated December 14, 2011 (Filed With SEC on December 14, 2011)
- VOTING AGREEMENT (Filed With SEC on March 31, 2011)
- MASTER SERVICES AGREEMENT (Filed With SEC on March 14, 2008)
